BioPoly, LLC news

FORT WAYNE, IN – BioPoly LLC has announced that the first BioPoly^® Great Toe surgery in the U.S. was completed on September 30, 2021. The surgery was performed by Dr. Steve Herbst of Central Indiana Orthopedics in Muncie, Indiana.

“The BioPoly Great Toe implant addresses a large unmet need in the market, and we are thrilled to have it available in the U.S. now. This small implant has a lot of technology packed into it and solves many of the issues that have

FORT WAYNE, IN – BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly^® Great Toe Implant.  With this FDA clearance, the BioPoly technology is available for the first time in the U.S. 

BioPoly first received regulatory approval in 2012 for its knee implants in Europe. “Although we have been in patients in Europe with our knee implants for nearly 10 years, we are extremely excited to be able to en

FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with Canada-based distributor, Verve Medical Products, Inc., to distribute the BioPoly^® partial resurfacing family of products throughout Canada, with distribution initially taking place through the Canadian SAP. Verve Medical Products specializes in bringing medical-surgical products to Canada through its distribution and regulatory services.  Herb Schwartz, BioPoly President, said &l

FORT WAYNE, IN – BioPoly LLC has announced that the Company has further expanded its intellectual property portfolio. The Company was granted another international patent for its partial resurfacing implants which protects the innovative implant designs. In addition to patents that cover the design of its implants, several U.S. and international patents have also been granted that address the Company’s unique BioPoly^® material.  The Company’s IP portfolio

FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants which protects the innovative implant designs. The Company’s intellectual property portfolio also consists of patents that address its unique BioPoly^® material.  This most recent patent further adds to the Company’s IP portfolio, providing assurance that all aspects of the implants, material, and surgical technique are protected throug

FORT WAYNE, IN – BioPoly, LLC announced today that it has fully subscribed its latest round of private equity financing of $2M.  The financing round also includes oversubscription funding of $890k.  BioPoly has now raised over $20M through its initial grants ($3.27M) and private equity offerings.  The funds received from the most recent private offering will be used to bring products to the US market as well as launch product line extension for products currently approved

FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its innovative BioPoly^® material, which is currently being used to replace damaged cartilage in joints. Where some of the other BioPoly patents address the design of the implants, this patent family focuses on the material itself. This most recent patent, regarding material derivatives, adds to the Company’s intellectual property portfolio to provide the assurance that all aspec